The global drugs of abuse testing market size was valued at US$ 4,752.5 Mn in 2018 and is projected to expand at a CAGR of 5.5% from 2019 to 2026. Increase in impact of drug and alcohol abuse on public health, rise in demand for drug abuse testing among private employers, and surge in abuse of prescription drugs are anticipated to augment the global market from 2019 to 2026.
Testing for drugs of abuse is done in-house or onsite in order to detect drugs in the human body (saliva, blood, sweat) which are banned by the government for human consumption. The testing can be done using various technologies that involve rapid testing devices as well as analyzers which are laboratory instruments. Increasing demand for illicit drugs and increasing prevalence of drug addicts are driving the growth of the drugs of abuse testing market globally.
The report analyzes and forecasts the drugs of abuse testing market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of drugs of abuse testing, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major drugs of abuse testing companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of drugs of abuse testing upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of drugs of abuse testing and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global drugs of abuse testing market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the drugs of abuse testing market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of drugs of abuse testing market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report profiles major players in the global drugs of abuse testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players operating in the global drugs of abuse testing market are Alere, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Drägerwerk AG & Co. KGaA, Siemens Healthcare, Express Diagnostics International Inc., and Shimadzu Corporation.
Report Segmentation:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drugs of Abuse Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Regulatory Scenario
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Trends
4.5. Market Revenue Projections (US$ Mn)
4.6. Market Outlook
4.7. Porter’s Five Forces Analysis
4.8. Value Chain Analysis
4.9. Technology Assessment
4.10. Global Demand and Supply Scenario
5. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product Type
5.1. Introduction
5.2. Product Comparison Matrix
5.3. Market Revenue Share (%) and Attractiveness Analysis, by Product Type
5.4. Market Size (US$ Mn) Forecast, by Product Type
5.4.1. Analyzers
5.4.1.1. Immunoassay Analyzers
5.4.1.2. Chromatographic Devices
5.4.1.3. Breath Analyzers
5.4.2. Rapid Testing Devices
5.4.2.1. Urine Testing Devices
5.4.2.2. Oral Fluid Testing Devices
5.4.3. Consumables
5.4.3.1. Fluid Collection Devices
5.4.3.2. Others
6. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction
6.2. Market Revenue Share (%) and Attractiveness Analysis, by Sample Type
6.3. Market Size (US$ Mn) Forecast, by Sample Type
6.3.1. Saliva
6.3.2. Breath
6.3.3. Urine
6.3.4. Blood
6.3.5. Hair & Sweat
7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Testing Type
7.1. Introduction
7.2. Market Revenue Share (%) and Attractiveness Analysis, by Testing Type
7.3. Market Size (US$ Mn) Forecast, by Testing Type
7.3.1. Pain Management Testing
7.3.2. Criminal Justice Testing
7.3.3. Workplace Screening
8. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Market Revenue Share (%) and Attractiveness Analysis, by End-user
8.3. Market Size (US$ Mn) Forecast, by End-user
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. On-the-spot Testing
8.3.4. Forensic Laboratories
9. Global Drugs of Abuse Testing Market Analysis and Forecast, by Region
9.1. Market Revenue Share (%) and Attractiveness Analysis, by Region
9.2. Market Size (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East and Africa
10. North America Drugs of Abuse Testing Market Analysis and Forecast
10.1. Market Overview
10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2026
10.1.2. Testing Market Attractiveness Analysis, by Country
10.2. Market Value Share Analysis, by Product Type
10.2.1. Analyzers
10.2.1.1. Immunoassay Analyzers
10.2.1.2. Chromatographic Devices
10.2.1.3. Breath Analyzers
10.2.2. Rapid Testing Devices
10.2.2.1. Urine Testing Devices
10.2.2.2. Oral Fluid Testing Devices
10.2.3. Consumables
10.2.3.1. Fluid Collection Devices
10.2.3.2. Others
10.3. Market Value Share Analysis, by Sample Type
10.3.1. Saliva
10.3.2. Breath
10.3.3. Urine
10.3.4. Blood
10.3.5. Hair & Sweat
10.4. Market Value Share Analysis, by Testing Type
10.4.1. Pain Management
10.4.2. Criminal Justice Testing
10.4.3. Workplace Screening
10.5. Market Value Share Analysis, by End-user
10.5.1. Hospitals
10.5.2. Diagnostics Laboratories
10.5.3. On-The-Spot Testing
10.5.4. Forensic Laboratories
10.6. Market Value Share Analysis, by Country
10.6.1. U.S.
10.6.2. Canada
10.7. Market Size (US$ Mn) Forecast
10.7.1. By Product Type
10.7.2. By Sample Type
10.7.3. By Testing Type
10.7.4. By End-user
10.7.5. By Country
10.8. Market Attractiveness Analysis
10.8.1. By Product Type
10.8.2. By Sample Type
10.8.3. By Testing Type
10.8.4. By End-user
10.8.5. By End-user
11. Europe Drugs of Abuse Testing Market Analysis and Forecast
11.1. Market Overview
11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2026
11.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
11.2. Market Value Share Analysis, by Product Type
11.2.1. Analyzers
11.2.1.1. Immunoassay Analyzers
11.2.1.2. Chromatographic Devices
11.2.1.3. Breath Analyzers
11.2.2. Rapid Testing Devices
11.2.2.1. Urine Testing Devices
11.2.2.2. Oral Fluid Testing Devices
11.2.3. Consumables
11.2.3.1. Fluid Collection Devices
11.2.3.2. Others
11.3. Market Value Share Analysis, by Sample Type
11.3.1. Saliva
11.3.2. Breath
11.3.3. Urine
11.3.4. Blood
11.3.5. Hair & Sweat
11.4. Market Value Share Analysis, by Testing Type
11.4.1. Pain Management
11.4.2. Criminal Justice Testing
11.4.3. Workplace Screening
11.5. Market Value Share Analysis, by End-user
11.5.1. Hospitals
11.5.2. Diagnostics Laboratories
11.5.3. On-the-Spot Testing
11.5.4. Forensic Laboratories
11.6. Market Value Share Analysis, by Country/Sub-region
11.6.1. U.K.
11.6.2. France
11.6.3. Germany
11.6.4. Italy
11.6.5. Spain
11.6.6. Russia
11.6.7. Rest of Europe
11.7. Market Size (US$ Mn) Forecast
11.7.1. By Product Type
11.7.2. By Sample Type
11.7.3. By Testing Type
11.7.4. By End-user
11.7.5. By Country/Sub-region
11.8. Market Attractiveness Analysis
11.8.1. By Product Type
11.8.2. By Sample Type
11.8.3. By Testing Type
11.8.4. By End-user
12. Asia Pacific Drugs of Abuse Testing Market Analysis and Forecast
12.1. Market Overview
12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2026
12.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
12.2. Market Value Share Analysis, by Product Type
12.2.1. Analyzers
12.2.1.1. Immunoassay Analyzers
12.2.1.2. Chromatographic Devices
12.2.1.3. Breath Analyzers
12.2.2. Rapid Testing Devices
12.2.2.1. Urine Testing Devices
12.2.2.2. Oral Fluid Testing Devices
12.2.3. Consumables
12.2.3.1. Fluid Collection Devices
12.2.3.2. Others
12.3. Market Value Share Analysis, by Sample Type
12.3.1. Saliva
12.3.2. Breath
12.3.3. Urine
12.3.4. Blood
12.3.5. Hair & Sweat
12.4. Market Value Share Analysis, by Testing Type
12.4.1. Pain Management
12.4.2. Criminal Justice Testing
12.4.3. Workplace Screening
12.5. Market Value Share Analysis, by End-user
12.5.1. Hospitals
12.5.2. Diagnostics Laboratories
12.5.3. On-the-Spot Testing
12.5.4. Forensic Laboratories
12.6. Market Value Share Analysis, by Country/Sub-region
12.6.1. Japan
12.6.2. China
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Size (US$ Mn) Forecast
12.7.1. By Product Type
12.7.2. By Sample Type
12.7.3. By Testing Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. By Sample Type
12.8.3. By Testing Type
12.8.4. By End-user
13. Latin America Drugs of Abuse Testing Market Analysis and Forecast
13.1. Market Overview
13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2026
13.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
13.2. Market Value Share Analysis, by Product Type
13.2.1. Analyzers
13.2.1.1. Immunoassay Analyzers
13.2.1.2. Chromatographic Devices
13.2.1.3. Breath Analyzers
13.2.2. Rapid Testing Devices
13.2.2.1. Urine Testing Devices
13.2.2.2. Oral Fluid Testing Devices
13.2.3. Consumables
13.2.3.1. Fluid Collection Devices
13.2.3.2. Others
13.3. Market Value Share Analysis, by Sample Type
13.3.1. Saliva
13.3.2. Breath
13.3.3. Urine
13.3.4. Blood
13.3.5. Hair & Sweat
13.4. Market Value Share Analysis, by Testing Type
13.4.1. Pain Management
13.4.2. Criminal Justice Testing
13.4.3. Workplace Screening
13.5. Market Value Share Analysis, by End-user
13.5.1. Hospitals
13.5.2. Diagnostics Laboratories
13.5.3. On-the-Spot Testing
13.5.4. Forensic Laboratories
13.6. Market Value Share Analysis, by Country/Sub-region
13.6.1. Mexico
13.6.2. Brazil
13.6.3. Rest of Latin America
13.7. Market Size (US$ Mn) Forecast
13.7.1. By Product Type
13.7.2. By Sample Type
13.7.3. By Testing Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
13.8. Market Attractiveness Analysis
13.8.1. By Product Type
13.8.2. By Sample Type
13.8.3. By Testing Type
14. Middle East & Africa Drugs of Abuse Testing Market Analysis and Forecast
14.1. Market Overview
14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2026
14.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
14.2. Market Value Share Analysis, by Product Type
14.2.1. Analyzers
14.2.1.1. Immunoassay Analyzers
14.2.1.2. Chromatographic Devices
14.2.1.3. Breath Analyzers
14.2.2. Rapid Testing Devices
14.2.2.1. Urine Testing Devices
14.2.2.2. Oral Fluid Testing Devices
14.2.3. Consumables
14.2.3.1. Fluid Collection Devices
14.2.3.2. Others
14.3. Market Value Share Analysis, by Sample Type
14.3.1. Saliva
14.3.2. Breath
14.3.3. Urine
14.3.4. Blood
14.3.5. Hair & Sweat
14.4. Market Value Share Analysis, by Testing Type
14.4.1. Pain Management
14.4.2. Criminal Justice Testing
14.4.3. Workplace Screening
14.5. Market Value Share Analysis, by End-user
14.5.1. Hospitals
14.5.2. Diagnostics Laboratories
14.5.3. On-the-Spot Testing
14.5.4. Forensic Laboratories
14.6. Market Value Share Analysis, by Country/Sub-region
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Size (US$ Mn) Forecast
14.7.1. By Product Type
14.7.2. By Sample Type
14.7.3. By Testing Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
14.8. Market Attractiveness Analysis
14.8.1. By Product Type
14.8.2. By Sample Type
14.8.3. By Testing Type
14.8.4. By End-user
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company (2017)
15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
15.3.1. F. Hoffmann-La Roche AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Siemens Healthineers (Siemens AG)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Thermo Fisher Scientific, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Abbott
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Shimadzu Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Laboratory Corporation of America Holdings
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Danaher
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Drägerwerk AG & Co. KGaA
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Express Diagnostics International, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers